Ross Stores
ROST
225.53
+1.32
+0.59%
Ross Stores
US · ROST
#318 by market cap
Listed 1970
225.53
+1.32
+0.59%
Live - 5344 symbols - heartbeat 227s ago
· 2026-10-08 08:07
Pre-market
226.82
+0.57%
After-hours
225.53
0.00%
Overnight
224.34
-0.53%
- Market cap
- 72.05B
- P/E (TTM)i
- 27.27
- P/Bi
- 10.68
- EPSi
- 6.61
- Div yieldi
- 0.75%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on ROST?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.30, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.67% YoY
Margins
- Gross margin
- 27.71%
- Operating margin
- 11.90%
- Net margin
- 9.43%
Key ratios & quality
- Enterprise valuei
- 69.70B
- PEG ratioi
- 2.21
- Altman Z-Scorei
- 7.30
PEG uses trailing P/E against the 3-year net income growth rate (12.36%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.98B | 16.04B | 12.53B | 18.92B | 18.70B | 20.38B | 21.13B | 22.75B |
| Gross profit | 4.26B | 4.50B | 2.69B | 5.21B | 4.75B | 5.58B | 5.87B | 6.30B |
| Selling & admin expenses | 2.22B | 2.36B | 2.50B | 2.87B | 2.76B | 3.27B | 3.28B | 3.60B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.04B | 2.15B | 189.71M | 2.33B | 1.99B | 2.31B | 2.59B | 2.71B |
| Pretax profit | 2.05B | 2.16B | 106.30M | 2.26B | 1.99B | 2.47B | 2.76B | 2.84B |
| Tax | 463.42M | 503.36M | 20.92M | 535.95M | 475.45M | 597.26M | 666.42M | 697.11M |
| Net profit | 1.59B | 1.66B | 85.38M | 1.72B | 1.51B | 1.87B | 2.09B | 2.15B |
| Basic EPS | 4 | 5 | 0 | 5 | 4 | 6 | 6 | 7 |
| Diluted EPS | 4.26 | 4.60 | 0.24 | 4.87 | 4.38 | 5.56 | 6.32 | 6.61 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 4.98B | 5.53B | 5.60B | 6.64B | 6.01B | 6.26B |
| Gross profit | 1.40B | 1.53B | 1.57B | 1.80B | 1.78B | 2.12B |
| Selling & admin expenses | 797.14M | 888.71M | 920.00M | 990.10M | 975.86M | 1.02B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 606.47M | 638.27M | 648.50M | 814.12M | 804.03M | 1.10B |
| Pretax profit | 640.88M | 670.62M | 682.40M | 848.26M | 837.48M | 1.13B |
| Tax | 161.63M | 162.63M | 170.46M | 202.40M | 187.51M | 283.46M |
| Net profit | 479.25M | 508.00M | 511.94M | 645.87M | 649.96M | 851.30M |
| Basic EPS | 1 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 1.47 | 1.56 | 1.58 | 2.00 | 2.02 | 2.66 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.40B | 3.43B | 6.69B | 7.47B | 6.90B | 7.40B | 7.54B | 7.64B |
| Cash & ST investments | 1.41B | 1.35B | 4.82B | 4.92B | 4.55B | 4.87B | 4.73B | 4.59B |
| Inventory | 1.75B | 1.83B | 1.51B | 2.26B | 2.02B | 2.19B | 2.44B | 2.63B |
| Total assets | 6.07B | 9.35B | 12.72B | 13.64B | 13.42B | 14.30B | 14.91B | 15.55B |
| Total current liabilities | 2.01B | 2.70B | 3.97B | 4.21B | 3.64B | 4.19B | 4.66B | 4.83B |
| Short-term debt | -- | 564.48M | 663.03M | 630.52M | 655.98M | 933.34M | 1.40B | 1.23B |
| Long-term debt | 312.44M | 312.89M | 2.45B | 2.45B | 2.46B | 2.21B | 1.52B | 1.02B |
| Total liabilities | 2,767,945,000.00 | 5,989,118,000.00 | 9,427,227,000.00 | 9,580,206,000.00 | 9,127,880,000.00 | 9,428,783,000.00 | 9,396,137,000.00 | 9,361,294,000.00 |
| Total equity | 3.31B | 3.36B | 3.29B | 4.06B | 4.29B | 4.87B | 5.51B | 6.19B |
| Retained earnings | 2.30B | 2.33B | 2.19B | 2.87B | 3.05B | 3.55B | 4.13B | 4.73B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 6.88B | 6.93B | 7.63B | 7.64B | 7.57B | 7.88B |
| Cash & ST investments | 3.78B | 3.85B | 4.06B | 4.59B | 4.13B | 4.29B |
| Inventory | 2.67B | 2.61B | 3.13B | 2.63B | 2.98B | 3.09B |
| Total assets | 14.30B | 14.50B | 15.41B | 15.55B | 15.55B | 15.98B |
| Total current liabilities | 4.44B | 4.39B | 5.02B | 4.83B | 4.91B | 4.89B |
| Short-term debt | 1.20B | 1.22B | 1.22B | 1.23B | 976.87M | 993.76M |
| Long-term debt | 1.02B | 1.02B | 1.02B | 1.02B | 776.84M | 777.05M |
| Total liabilities | 8,728,538,000.00 | 8,762,950,000.00 | 9,530,964,000.00 | 9,361,294,000.00 | 9,249,569,000.00 | 9,239,096,000.00 |
| Total equity | 5.58B | 5.73B | 5.88B | 6.19B | 6.31B | 6.74B |
| Retained earnings | 4.22B | 4.34B | 4.47B | 4.73B | 4.92B | 5.32B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.07B | 2.17B | 2.25B | 1.74B | 1.69B | 2.51B | 2.36B | 3.03B |
| Depreciation & amortization | 330.36M | 350.89M | 364.25M | 360.66M | 394.66M | 419.43M | 446.79M | 509.39M |
| Free cash flow | 1.65B | 1.62B | 1.84B | 1.18B | 1.04B | 1.75B | 1.64B | 2.21B |
| Dividends paid | -337.19M | -369.79M | -101.40M | -405.12M | -431.30M | -454.81M | -488.72M | -528.09M |
| Stock buybacks / issuance | -1.13B | -1.34B | -177.69M | -707.34M | -998.85M | -998.56M | -1.14B | -1.13B |
| Ending cash balance | 1.48B | 1.41B | 4.95B | 4.98B | 4.61B | 4.94B | 4.80B | 4.66B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 409.72M | 668.36M | 827.09M | 1.12B | 836.01M | 875.76M |
| Depreciation & amortization | 115.94M | 126.40M | 132.19M | 134.87M | 132.60M | 140.19M |
| Free cash flow | 202.34M | 466.64M | 617.83M | 920.81M | 627.06M | 624.50M |
| Dividends paid | -133.30M | -132.34M | -131.56M | -130.89M | -143.56M | -142.63M |
| Stock buybacks / issuance | -322.65M | -266.79M | -277.96M | -262.50M | -452.92M | -321.17M |
| Ending cash balance | 3.85B | 3.91B | 4.13B | 4.66B | 4.20B | 4.36B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 49.96 | 49.84 | 2.57 | 46.87 | 36.22 | 40.93 | 40.28 | 36.68 |
| ROA %i | 26.92 | 21.54 | 0.77 | 13.07 | 11.18 | 13.53 | 14.32 | 14.09 |
| ROIC %i | 45.27 | 29.86 | 1.92 | 19.02 | 15.39 | 16.98 | 17.98 | 18.09 |
| 5-year avg ROE %i | 45.18 | 46.52 | 38.44 | 39.25 | 37.09 | 35.29 | 33.37 | 40.20 |
| EBIT margin %i | 13.80 | 13.55 | 1.55 | 12.34 | 11.06 | 12.49 | 13.35 | 12.66 |
| FCF / sales %i | 11.03 | 10.08 | 14.69 | 6.24 | 5.54 | 8.60 | 7.75 | 9.70 |
| Current ratioi | 1.69 | 1.27 | 1.69 | 1.77 | 1.90 | 1.77 | 1.62 | 1.58 |
| Quick ratioi | 0.75 | 0.54 | 1.24 | 1.20 | 1.29 | 1.20 | 1.05 | 0.99 |
| Debt / assetsi | 5.14 | 37.31 | 45.08 | 41.22 | 42.53 | 40.19 | 38.12 | 33.52 |
| LT debt / equityi | 9.45 | 87.03 | 154.07 | 122.94 | 117.77 | 98.83 | 77.68 | 64.40 |
| Interest coveragei | 126.00 | 223.21 | 2.21 | 31.05 | 25.67 | 34.36 | 44.50 | 75.91 |
| Revenue CAGR (3Y) %i | 7.86 | 7.62 | -3.93 | 8.08 | 5.24 | 17.59 | 3.76 | 6.76 |
| Net income CAGR (3Y) %i | 15.86 | 14.12 | -60.28 | 2.76 | -3.08 | 180.01 | 6.67 | 12.36 |
| FCF CAGR (3Y) %i | 19.88 | 8.62 | 12.00 | -10.60 | -13.79 | -1.64 | 11.49 | 28.71 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 39.57 | 37.98 | 37.43 | 36.68 | 38.98 | 42.63 |
| ROA %i | 14.46 | 14.14 | 13.76 | 14.09 | 15.51 | 17.45 |
| ROIC %i | 18.35 | 17.90 | 17.94 | 18.09 | 20.48 | 22.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.26 | 12.93 | 12.75 | 12.66 | 12.92 | 14.42 |
| FCF / sales %i | 7.56 | 7.81 | 8.91 | 9.70 | 11.07 | 11.38 |
| Current ratioi | 1.55 | 1.58 | 1.52 | 1.58 | 1.54 | 1.61 |
| Quick ratioi | 0.89 | 0.92 | 0.85 | 0.99 | 0.88 | 0.93 |
| Debt / assetsi | 35.06 | 34.96 | 33.66 | 33.52 | 30.37 | 29.65 |
| LT debt / equityi | 68.41 | 67.21 | 67.40 | 64.40 | 59.42 | 55.54 |
| Interest coveragei | 48.13 | 55.99 | 64.99 | 75.91 | 92.85 | 111.40 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Home Accents and Bed and Bath is the largest reported line at 24.00% of revenue, across 6 reported segments.
- No single line clears half of revenue; Ladies is next at 23.00%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Home Accents and Bed and Bath24.00%
Ladies23.00%
Men's16.00%
Accessories, Lingerie, Fine Jewelry, and Cosmetics15.00%
Shoes13.00%
Children's9.00%
Quote time 2026-10-08 08:07:08 · For reference only, not investment advice and not tailored to your situation.